Ovatodiolide suppresses allergic airway inflammation and hyperresponsiveness in a murine model of asthma

Chien Neng Wang, Yueh Lun Lee, Yu Pei Lin, Wen Hui Chung, Yew Min Tzeng, Chen Chen Lee

研究成果: 雜誌貢獻文章同行評審

1 引文 斯高帕斯(Scopus)

摘要

Asthma, a complex pulmonary allergic disease, major therapy is applied of drugs to control the disease, but quickly recur after the drugs are stopped. In patients with severe asthma may show steroid resistance and would benefit from the development of novel therapeutic drugs.Ovatodiolide, a unique macrocyclic diterpenoid isolated from Anisomeles indica, showed therapeutic potential for the treatment of allergic asthma. As a model of allergic inflammation, we used ovalbumin (OVA)-immunized mice, which displayed T helper cell type 2 (TH2) cytokine expression in bronchoalveolar lavage fluid (BALF), as well as airway inflammation and hyperresponsiveness (AHR). The results showed that ovatodiolide suppressed TH2 activation, including cell proliferation and production of the TH2 related cytokines, interleukin (IL)-4, IL-5, IL-13, IL-33, eosinophil chemotactic protein (eotaxin), and also reduced airway hyperresponsiveness. In this study, ovatodiolide inhibited allergic asthma through downregulation of TH2 responses in a murine model of asthma.
原文英語
期刊European Journal of Pharmacology
DOIs
出版狀態接受/付印 - 2017

ASJC Scopus subject areas

  • Pharmacology

指紋 深入研究「Ovatodiolide suppresses allergic airway inflammation and hyperresponsiveness in a murine model of asthma」主題。共同形成了獨特的指紋。

引用此